The Henry Wallman prize is an innovation prize in medical technology, which from 2018 will be awarded annually to young researchers or graduate students who, in close collaboration between expertise in technology and health care, successfully have transferred new knowledge from academia to practical medical care. Henry Wallman came to Chalmers in 1948, and was a pioneer in biomedical engineering research and development. The Foundation for Biomedical Engineering (Stiftelsen Medicin och Teknik) at Chalmers is hosting the prize. The scholarship amounts to SEK 50.000.
The very first winner of the Henry Wallman prize is Sabine Reinfeldt, who is an Associate Professor in Biomedical Engineering at the department of Electrical Engineering at Chalmers University of Technology in Gothenburg. Reinfeldt receives the prize for her research on bone conduction hearing aids, and for her great ability to build bridges between disciplines.
When? 19 September, 12:30 – 16:30 (starting with a lunch mingle 12:30-13:30)
Where? Kammaren, Vita stråket 12, Sahlgrenska University Hospital
12.30-13.30 Lunch mingle in the lobby
13.30-13.45 Presentation of the The Foundation for Biomedical Engineering and the Henry Wallman prize
13.45-14.15 “Bone conduction projects during 40 years”, Bo Håkansson
14.15-14.45 “BCI – you couldn’t do it without me”, Måns Eeg-Olofsson and Sabine Reinfeldt
14.45-15.15 “Decision making in hearing implants: a matter of facts?”, Myrthe Hol
15.15-15.30 Prize ceremony
15.30-16.00 Fika and mingle with Sabine and the other guests
Bo Håkansson is Professor in Biomedical Engineering in the same unit and department at Chalmers as Reinfeldt. Håkansson started in the field of bone conduction hearing in 1977 as a PhD student and has developed, amongst other devices, the bone-anchored hearing aid, used by more than 250 000 patients. He has invented the bone conduction implant (BCI), which is the main focus of several of Reinfeldt’s studies. Reinfeldt and Håkansson has worked together since 2003, when Reinfeldt started her PhD studies.
Måns Eeg-Olofsson is Associate Professor and MD specialist in Ear-Nose-Throat (ENT) and Audiology at the ENT department at Sahlgrenska University Hospital in Gothenburg, Sweden. He is specialized in bone conduction hearing and has performed the first surgeries of the BCI in the clinical trial. He is the closest clinical collaborator at Sahlgrenska to Reinfeldt, Håkansson and the rest of the bone conduction hearing group at Chalmers. This collaboration has been very fruitful over the years, which Eeg-Olofsson and Reinfeldt will talk about in their speech.
Myrthe Hol is ENT surgeon at Radboud University Medical Center, Nijmegen, the Netherlands, focusing on otology with particular attention to titanium temporal bone implants and auricular reconstruction/prosthesis. She combines her clinical duties with research on most of the bone conduction hearing devices on today´s market. There has been a long history of collaboration between the Chalmers and Nijmegen groups, and lately especially between Reinfeldt and Hol with joint projects and co-supervision of a PhD student.